Ken Griffin Pro Phase Labs, Inc. Put Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$4.18 - $7.35 $20,900 - $36,750	5,000 Added 500.0%	6,000 $25,000
Q1 2024 May 15, 2024	BUY	$4.47 - $6.47 $4,470 - $6,470	1,000 New	1,000 $6,000
Q3 2023 Nov 14, 2023	SELL	$4.23 - $7.53 $52,452 - $93,372	-12,400 Reduced 73.81%	4,400 $19,000
Q2 2023 Aug 14, 2023	BUY	$7.15 - $9.78 $51,480 - $70,416	7,200 Added 75.0%	16,800 $121,000
Q1 2023 May 15, 2023	SELL	$6.62 - $9.57 $20,522 - $29,667	-3,100 Reduced 24.41%	9,600 $73,000
Q4 2022 Feb 14, 2023	SELL	$8.78 - $12.47 $54,435 - $77,314	-6,200 Reduced 32.8%	12,700 $122,000
Q3 2022 Nov 14, 2022	BUY	$8.96 - $14.7 $169,344 - $277,830	18,900 New	18,900 $213,000

1.64M

500

Ticker PRPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 16,024,400
Market Cap $12.5M
Description
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.